Latest Derivatives News

Chilwa Minerals reports encouraging metallurgical testwork from its Mposa Deposit, confirming the potential for commercial-grade ilmenite and promising by-products including zircon and rare earth minerals. These findings will shape the upcoming Scoping Study and flowsheet design.

Neurizon Therapeutics has formally responded to the FDA's clinical hold on its lead ALS drug NUZ-001, submitting new animal safety data. The company aims to join the HEALEY ALS Platform Trial by late 2025, pending regulatory approval.

Waypoint REIT’s half-year update reveals a 3.4% portfolio valuation increase to $2.89 billion, alongside a strategic pause in its $50 million buyback program after $32.9 million in purchases.

Westgold Resources capped FY25 with record quarterly gold production and a $132 million treasury boost, while announcing a maiden 2.3 million ounce resource at its Fletcher Zone.

Alternative Investment Trust (ASX, AIQ) announces a special unfranked distribution of AUD 0.04647 per unit, representing a full return of capital payable in early August.

Global Masters Fund Limited has released its quarterly update confirming stable convertible note conversions and a low loan-to-value ratio, underscoring its solid financial footing as of June 2025.

ActivEX Limited has announced a maiden JORC-compliant inferred gold resource of 310,000 ounces at its Mt Hogan historic gold mine within the Gilberton JV project in Queensland. This milestone sets the stage for further exploration and potential development in a highly prospective gold region.

Nova Minerals has launched its 2025 drilling campaign at the high-grade RPM deposit in Alaska, deploying multiple rigs to test resource extensions and new targets. Early geological observations suggest significant potential, with assay results awaited in the coming months.

4DMedical has renewed its three-year contract with the University of Michigan Medical Center, reinforcing its foothold in US respiratory imaging. Alongside, a pivotal clinical study validates its technology’s ability to detect early lung disease, while a substantial Australian grant boosts its AI research.

Sun Silver Limited’s re-assay program at its Maverick Springs Project in Nevada has uncovered silver grades up to 26% higher than historical data, suggesting a significant underestimation in the existing resource. This finding could reshape the project’s valuation and future development plans.

Aspen Group has secured a $19 million portfolio of 19 retirement village properties in Adelaide, aiming to convert leases and boost residential rental income over time.

Imugene Limited has launched a A$37.5 million capital raising to advance its promising off-the-shelf CAR T therapy, azer-cel, following encouraging Phase 1b data showing a 75% overall response rate in lymphoma patients.